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Introduction
Fanconi anemia (FA) is a rare autosomal recessive disorder that belongs to the group of chromosomal instability syndromes. FA cells of all organ tissues are hypersensitive to DNA cross-linking agents and to oxygen and have cell cycle abnormalities. Its clinical features include progressive bone marrow failure, skeletal and urogenital malformations, skin hyperpigmentation, increased susceptibility to malignancy and reduced fertility. 1, 2 As base-line, in non transplanted FA patients who reach adult age, the rate of successful pregnancy has been estimated at 15%. 3 Hematopoietic stem cell transplantation (HSCT), using an adapted attenuated conditioning regimen, represents the only curative therapy capable of restoring normal hematopoiesis in patients with FA. In FA, the conditioning has been reduced because of the toxic effect of alkylating agents. 4 For this reason, most centers use low dose cyclophosphamide with or without irradiation assuming that this is the equivalent of a myeloablative conditioning considering the DNA repair defect related to the genetic mutation. 5 In order to describe fertility in female patients after transplant, we designed a multicenter retrospective analysis of post transplant pregnancy in FA patients.
Design and Methods
Fifteen transplant centers from 10 different countries participated in this survey. Centers that reported pregnancies after transplant were asked to fill in a specific disease form and the MED-B EBMT form including detailed information on diagnosis, transplant procedure, gynecological and obstetrics follow-up. 
Results and Discussion
Patient characteristics are summarized in There were 14 live births (9 males and 5 females). The 27-week premature baby weighted 870 g at birth and was kept in an intensive care unit during her first 45 days of life. Ultimately her development was normal.
Currently, they are all healthy children with normal growth and development without congenital abnormalities and normal blood cytogenetics.
The patients did not receive any additional treatment after delivery and their hematological status remained stable during and after pregnancy.
Unfortunately, one patient presented with tongue and esophagus squamous cell carcinoma and died as a result of this malignant complication 20 years after transplant and 15 years after her first pregnancy. The other nine mothers are alive and well.
Pregnancy following HSCT after myeloablative conditioning is considered to be a rare event [9] [10] [11] [12] [13] [14] . In the largest multicenter European retrospective study on pregnancy outcomes after transplant, 232 out of 37362 autologous and allogeneic HSCT patients (0,6%) conceived after HSCT. 9 In Seattle, among 1522 disease free survivors following marrow transplant between August 1971 and January 1992, 41 female patients and partners of 35 male patients had 146 pregnancies after transplant. 10 The dose of irradiation required to destroy 50% of immature oocytes has been estimated at 2 Gy 15 .
Reduced ovarian volume and low inhibin B and anti Mullerian hormone concentrations in survivors with regular menses may be markers of incipient ovarian failure 15 . In addition, uterine damage manifest by impaired growth and blood flow is a likely consequence of pelvic irradiation. 11 However, the true incidence of pregnancy and pregnancyrelated complications after transplantation are unknown.
12.13.14 Fanconi anemia patients post transplant are supposed to have an even lower probability of fertility recovery compared to other transplant groups and three distinct factors can be incriminated: hypergonadotropic hypogonadism related to FA status, radiotherapy and greater toxicity from chemotherapy in cells presenting increased sensitivity to DNA damage.
However, several isolated case reports of FA patients pregnancy post
HSCT have been published. , 6, 7, 8 Moreover, experimental studies suggested that FA complementation groups are required for mitotic proliferation of primordial germ cells and also that hormonal problems and sterility might be associated to specific mutations 16, 17 . Unfortunately, data regarding the complementation group or additional mutations were not available for most of the described patients in our study.
The magnitude of ovarian damage in females who received HSCT is drugspecific and dose-related. Furthermore, the age at exposure has a fundamental role as younger women need higher doses of irradiation and/or alkylating agents to produce irreversible ovarian failure. It is also known that few patients may recover gonad function spontaneously even being conditioned with CY and/or TBI after varying intervals of time. 18, 19 The increased sensitivity to DNA-damaging agents in FA requires the use of an attenuated conditioning regimen before HSCT to avoid lethal toxicity.
Nevertheless, patients with FA who undergo HSCT still present toxicity comparable to that of patients transplanted for other diseases given conventional conditioning regimens. Our data do not authorize to give any recommendation for conditioning Fanconi anemia patients, most regimens use now Fludarabine which decreases toxicity and improves engraftment. 
